Voyageur Pharmaceuticals Ltd. News
-
Voyageur Announces Proposed Private Placement
October 17, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) (“Voyageur” or the “Corporation”), is pleased to…
-
Voyageur Pharmaceuticals Grants Stock Options
September 25, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) (“Voyageur” or the “Company”) announces that…
-
Voyageur Pharmaceuticals Strengthens Leadership Team with Strategic Appointment of Dr. Ibrahim Hashmi as VP of Business Development
September 24, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (“Voyageur” or the “Company”) is pleased…
-
Voyageur Pharmaceuticals Appoints Dr. Iryna Saranchova as Chief Science Officer, Enhancing the Company’s Research and Innovation Leadership
September 17, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (“Voyageur” or the “Company”) proudly announces…
-
Voyageur Introduces Five New Barium Contrast Formulations Setting New Standards in Medical Imaging Industry
September 05, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (“Voyageur” or the “Company”) announces that…
-
Voyageur Pharmaceuticals Grants Deferred Share Units
July 9, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC: VYYRF) (“Voyageur” or the “Corporation”), a provider…
-
Testing to Begin of Radiology Endohedral Fullerenes, a Milestone in Nanotechnology & Drug Development
June 11, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (“Voyageur” or the “Company”) announces that…
-
Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium Contrast
May 28, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (“Voyageur” or the “Company”) proudly announces…
-
Voyageur Pharmaceuticals Ltd Grants Deferred Share Units Compensation to Independent Directors
April 3, 2024 (Source) — Voyageur Pharmaceuticals Ltd (TSXV:VM) (OTC: VYYRF) (“Voyageur” or the “Corporation”), a provider of innovative…
-
Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options
March 26, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (“Voyageur” or the “Company”), announces that…
